Does abstinence from smoking or a transdermal nicotine system influence atracurium-induced neuromuscular block?

What Was Tested

This randomized controlled trial paper looks at Therapeutic nicotine (patch, non-peptide).

The purpose of the present study was to investigate the interaction of chronic smoking and the actions of atracurium (ATR).

Why It Was Studied

The TD-NICO and ABST groups refrained from smoking for at least 10 h before the induction of anesthesia.

A third group was allowed to smoke until 1-3 h before anesthesia (SMOK, n = 20).

Who Took Part

The study group was 30 patients.

By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Neither the patients nor the staff measuring them knew who was on Therapeutic nicotine (patch, non-peptide), so expectations could not easily colour the readings.

The comparison arm used a placebo, so changes seen with Therapeutic nicotine (patch, non-peptide) could be set against what happens without it.

What Was Measured

PubMed files the paper under topics including Administration, Cutaneous, Anesthetics, Combined, Atracurium, Electromyography, Neuromuscular Blockade, Neuromuscular Nondepolarizing Agents and Nicotine.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Therapeutic nicotine (patch, non-peptide) in 30 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 1998 (Anesthesia and analgesia), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.